Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Background: In the US in 2021, 76,080 kidney cancers are expected and >80% are renal cell carcinomas (RCCs). Along with excess fat, metabolic dysfunction is implicated in RCC etiology. To identify RCC-associated metabolites, we conducted a 1:1 matched case–control study nested within the Prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: McClain, Kathleen M., Sampson, Joshua N., Petrick, Jessica L., Mazzilli, Kaitlyn M., Gerszten, Robert E., Clish, Clary B., Purdue, Mark P., Lipworth, Loren, Moore, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785244/
https://www.ncbi.nlm.nih.gov/pubmed/36557227
http://dx.doi.org/10.3390/metabo12121189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785244/
https://www.ncbi.nlm.nih.gov/pubmed/36557227
http://dx.doi.org/10.3390/metabo12121189

Ejemplares similares